Portal de Periódicos da CAPES

A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction

2001; Elsevier BV; Volume: 75; Issue: 5 Linguagem: Inglês

10.1016/s0015-0282(01)01749-6

1556-5653

R. Boostanfar, John K. Jain, Daniel R. Mishell, Richard J. Paulson,

Gynecological conditions and treatments

Objective: To compare the rates of ovulation and pregnancy after tamoxifen citrate (TMX) or clomiphene citrate (CC) among anovulatory women with infertility.Design: Prospective randomized trial.Setting: Infertility clinic in a university teaching hospital.Patient(s): Eighty-six anovulatory women under 40 years of age undergoing ovulation induction.Intervention(s): The women were assigned randomly to receive either TMX or CC on cycle days 5–9.Main Outcome Measure(s): Rates of ovulation and pregnancy for the two treatment modalities.Result(s): The overall rate of ovulation in the TMX group was 50 of 113 (44.2%) and in the CC group, 41 of 91 (45.1%). There were 10 pregnancies in the TMX group and 6 pregnancies in the CC group. The cycle fecundity per ovulatory cycle was 20.0% in the TMX group and 14.6% in the CC group.Conclusion(s): The overall rate of ovulation and pregnancy were similar with TMX and CC. TMX is a suitable alternative agent to CC in the management of anovulatory infertility.